Search PubMed⌕ Search

Biomedical subjects

Marion Allen

Publications and source records attributed to Marion Allen.

6 recordsLinked to original sources

Ethical considerations for nurses in clinical trials.

Ethical issues arise for nurses involved in all phases of clinical trials regardless of whether they are caregivers, research nurses, trial co-ordinators or principal investigators. Potential problem areas centre on nurses' moral obligation related to methodological issues as well as the notions of beneficence/non-maleficence and autonomy. These ethical concerns can be highly upsetting to nurses if they are not addressed, so it is imperative that they are discussed fully prior to the initiation of a trial. Failure to resolve these issues can place both the conduct and the results of research in jeopardy.

Aged, 80 and over↗

Pad tests and self-reports of continence in men awaiting radical prostatectomy: establishing baseline norms for males.

AIMS: In this study, we report normal pad weight gain in a group self-reported continent men and compare the self-report data with the 24-hr pad test and the International Prostate Symptom Score (IPSS). MATERIALS AND METHODS: Subjects awaiting radical prostatectomy were consecutively recruited. Exclusion criteria were a previous history of urologic surgery, reported urinary incontinence, or a medical problem which could affect bladder function. RESULTS: Two hundred forty five men were enrolled. All were Caucasian, mean age 62.7 years, mean Gleason score 6.5, and mean PSA 8.3. At initial interview, all described themselves as continent of urine and 26 declined the 24-hr pad test because they were emphatic that they were continent. Of the 220 remaining, mean pad weight gain was 4.0 g on 24-hr pad test (SD 3.8; range 0-35.0 g), mean IPSS score was 7.23; 95 subjects scored > or = 8 (moderate), 13 scored > or = 20 (severe). The IPSS single Quality of Life (QOL) question and the 24 hr pad weight were not correlated; the summary IPSS score and pad weight had a correlation of 0.16 (P = 0.02) and the QOL question and the summary IPSS score had a correlation of 0.63 (P < 0.001). IPSS QOL scores were worse for those recording > or = 8 (P < 0.001). CONCLUSIONS: The range of weight gain between 0 and 35 g suggests that self-report alone of urinary continence is an inaccurate measure of continence for research purposes. We propose that a pad weight gain of 8 g or less is indicative of urinary continence in men.

Aged↗

Ethological methods to develop nursing knowledge.

Researchers from various fields use ethological methods to systematically observe, describe, and measure animal and human nonverbal behavior. The purpose of this article is to argue that their application in nursing will benefit development of descriptive-level knowledge about complex behavioral phenomena. To advance the argument for applying these methods in nursing, we examine the compatibility of the philosophical assumptions underlying ethology with nursing, assess if ethology can help nursing achieve some of its aims, and determine the benefits of using ethology when observation of a phenomenon is required. Neonatal pain is used to illustrate how ethology can be used to develop descriptive-level nursing knowledge and midrange theory.

Clinical Nursing Research↗

Building capacity through a collaborative international nursing project.

PURPOSE: To discuss: (a) physical, human, organizational, social, and cultural capital and (b) empowerment as two theoretical foundations for building capacity. METHODS: These theoretical notions are examined in an analysis of a joint project between the Department of Nursing, University of Ghana and the Faculty of Nursing at the University of Alberta, Canada. FINDINGS: Capacity for the management of international development projects was enhanced at both sites. Building capacity required mutual trust, tolerance of ambiguity, and a willingness to step into the unknown.

Alberta↗

Elk velvet antler in rheumatoid arthritis: phase II trial.

The purpose of this phase II clinical trial was to examine safety of elk velvet antler taken concurrently with rheumatoid arthritis medications and to determine efficacy by dose to enable sample size estimation and dose standardization for a larger study. Forty patients with stage II rheumatoid arthritis were randomly assigned to 1 of 4 arms of 10 patients each. One group received placebo and the other 3 groups received 2, 4, or 6 capsules (215 mg) of elk velvet antler with appropriate placebos to total 6 capsules daily. All subjects continued to take their arthritis medications. Outcome variables were reported adverse events and health status. At 1 month, there were no significant differences between groups in number of adverse events or health status. The greatest improvement was in the 6 elk velvet antler group, the least was in the placebo group. Differences were not statistically significant. It was concluded that elk velvet antler can be taken safely in conjunction with a number of rheumatoid arthritis medications and should be studied further to assess efficacy.

Aged↗